PLATFORM
LAB-ON-A-CHIP PLATFORM
Patented technology with associated image analysis software for cost-effective, high quality, large-throughput and data-rich assays
RESULTS
FASTER
LESS COST
BETTER DATA
UNIQUE
COMBINE
PERSONALISE
STRATIFY
FEATURES
DRUG PERFUSION
NO TUBING
PLUG & PLAY
Our platform, originally developed for oncology drug screening, supports 3D culture of a variety of cell types and disease models.
HOW IT WORKS
Generate 3D complex models of disease
The platform is suitable for developing spheroids, organoids, and 3D co-cultures using just a few thousand cells.
Facilitate drug combination screening
Test multiple therapy modalities on the same samples to quantify synergistic effects.
Test drugs in ‘in vivo-like’ conditions
Mimic human physiology at scale without the need for tubing or flow equipment.
Generate 3D complex models of disease
The platform is suitable for developing spheroids, organoids, and 3D co-cultures using just a few thousand cells.
Facilitate drug combination screening
Test multiple therapy modalities on the same samples to quantify synergistic effects.
Test drugs in ‘in vivo-like’ conditions
Mimic human physiology at scale without the need for tubing or flow equipment.
Why 3D and human tissue?
Testing drugs on patient-derived 3D models significantly improves the chance of finding clinically effective therapies
Why now?
Following FDA guidelines, the Modernization Act 2.0 elevates the need to phase out animal testing by 2035
